The Centers for Medicare and Medicaid Services and FDA introduced the RAPID coverage pathway, promising Medicare national coverage within two months of FDA market authorization. This development accelerates access to new medical devices for adults, significantly benefiting developers by reducing reimbursement delays. However, it exacerbates the existing gap in timely access to pediatric medical devices.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



